In this interview, a KOL in the US Midwest discusses their approach to treating epilepsy, including developmental and epileptic encephalopathies (DEEs) such as Dravet syndrome and Lennox-Gastaut syndrome. They also share their thoughts on upcoming pipeline therapies and the direction in which epilepsy treatment is headed.

This interview was conducted on 1 August 2024. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal. 

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.